98 related articles for article (PubMed ID: 7661103)
1. Impact of generic and therapeutic interchange incentives on community pharmacy.
Carroll NV
Am Pharm; 1995 Jul; NS35(7):27-34. PubMed ID: 7661103
[TBL] [Abstract][Full Text] [Related]
2. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
Murry L; Gerleman B; Urick B; Urmie J
J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
[TBL] [Abstract][Full Text] [Related]
3. Analysis of costs to dispense prescriptions in independently owned, closed-door long-term care pharmacies.
Carroll NV; Rupp MT; Holdford DA
J Manag Care Spec Pharm; 2014 Mar; 20(3):291-300. PubMed ID: 24564809
[TBL] [Abstract][Full Text] [Related]
4. Estimating a reasonable reimbursement for community pharmacies in third-party programs.
Carroll NV
Manag Care Interface; 1999 Feb; 12(2):73-6, 79-80. PubMed ID: 10346189
[TBL] [Abstract][Full Text] [Related]
5. Assessing changes in third-party gross margin for a single community pharmacy.
Urick BY; Urmie JM; Doucette WR; McDonough RP
J Am Pharm Assoc (2003); 2014; 54(1):27-34. PubMed ID: 24362541
[TBL] [Abstract][Full Text] [Related]
6. The spread: pilot study of an undocumented source of pharmacy benefit manager revenue.
Garis RI; Clark BE
J Am Pharm Assoc (2003); 2004; 44(1):15-21. PubMed ID: 14965148
[TBL] [Abstract][Full Text] [Related]
7. What use is generic prescribing?
Archer M
J R Coll Gen Pract; 1985 Jun; 35(275):293-5. PubMed ID: 4032358
[TBL] [Abstract][Full Text] [Related]
8. Do generics offer significant savings to the UK National Health Service?
Kanavos P
Curr Med Res Opin; 2007 Jan; 23(1):105-16. PubMed ID: 17257472
[TBL] [Abstract][Full Text] [Related]
9. Case study using descriptive analysis to estimate hidden costs in processing third party prescriptions.
Herrier RN; Spencer JR; Davis CD
J Am Pharm Assoc (Wash); 2000; 40(5):658-65. PubMed ID: 11029847
[TBL] [Abstract][Full Text] [Related]
10. Potential savings from generic prescribing and generic substitution in South Africa.
Karim SS; Pillai G; Ziqubu-Page TT; Cassimjee MH; Morar MS
Health Policy Plan; 1996 Jun; 11(2):198-205. PubMed ID: 10158460
[TBL] [Abstract][Full Text] [Related]
11. Undocumented source of pharmacy benefit manager revenue.
Siracuse MV; Clark BE; Garis RI
Am J Health Syst Pharm; 2008 Mar; 65(6):552-7. PubMed ID: 18319501
[TBL] [Abstract][Full Text] [Related]
12. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
Clark BE; Siracuse MV; Garis RI
Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
[TBL] [Abstract][Full Text] [Related]
13. Cost and price of comparable branded and generic pharmaceuticals.
Bloom BS; Wierz DJ; Pauly MV
JAMA; 1986 Nov; 256(18):2523-30. PubMed ID: 3773152
[TBL] [Abstract][Full Text] [Related]
14. The effects of competition on prescription-drug-product substitution.
Kralewski JE; Pitt L; Dowd B
N Engl J Med; 1983 Jul; 309(4):213-6. PubMed ID: 6866035
[TBL] [Abstract][Full Text] [Related]
15. Generic drugs versus brand names: switching could save money. Generic drugs have to go through the same FDA approvals as brand names, so they have the same quality.
Harv Womens Health Watch; 2013 Jul; 20(11):3. PubMed ID: 24818274
[No Abstract] [Full Text] [Related]
16. Implementation of a $4 generic drug program in a 340B pharmacy.
Bright DR; Adams AJ; Akala FO; Lengel AJ; Martin SJ; Powers MF
Am J Health Syst Pharm; 2010 Jun; 67(11):929-31. PubMed ID: 20484217
[TBL] [Abstract][Full Text] [Related]
17. Pharmacies receiving massive rebates from generic drug-makers.
Silversides A
CMAJ; 2006 Aug; 175(4):342. PubMed ID: 16908889
[No Abstract] [Full Text] [Related]
18. Financial impact from in-office dispensing of oral chemotherapy.
Howard A; Kerr J; McLain M; Modlin J
J Oncol Pharm Pract; 2019 Oct; 25(7):1570-1575. PubMed ID: 30249154
[TBL] [Abstract][Full Text] [Related]
19. Effect of a change in third party reimbursement rate on prescription gross margin.
Ganther JM; Kreling DH
J Am Pharm Assoc (Wash); 1999; 39(3):346-52. PubMed ID: 10363461
[TBL] [Abstract][Full Text] [Related]
20. An unhealthy public-private tension: pharmacy ownership, prescribing, and spending in the Philippines.
James CD; Peabody J; Solon O; Quimbo S; Hanson K
Health Aff (Millwood); 2009; 28(4):1022-33. PubMed ID: 19597201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
